CPF Submits Comments to CMS to Save Only Effective Therapy Available to P...(ublic Advisory Roundtable (PAR) to make ...),Health

PF patients are referred by their physicians to pulmonary rehab for medically supervised exercise and therapy designed to preserve some of their lung capacity, help their bodies avoid infections and sustain or improve, for as long as possible, their quality of life.

CMS accepts public comment on the proposed ruling until midnight tonight.

Top pulmonologists and PF experts joined the CPF in making its comments to CMS. They are:

• Marvin Schwarz, MD, James C. Campbell Professor of Medicine University of Colorado Health Sciences Center and the CPF's board of directors chairman
• James Loyd, MD, Medical Co-Director, Lung Transplant Program Medical Co-Director, FLOLAN Program for Primary Pulmonary Hypertension, Vanderbilt University Medical Center
• Adaani Frost, MD, Professor of Medicine, Baylor College of Medicine
• Paul Noble, MD, Professor of Medicine Division Chief, Allergy & Critical Care Medicine, Duke University Medical Center and the CPF's chairman of its scientific advisory board
• Glenn Rosen, MD, Associate Professor of Medicine, Division of Pulmonary & Critical Care Co-Director, Stanford University Lung Disease Center, Stanford Medical Center
• Marilyn Glassberg, MD, Assistant Professor of Medicine, Division of Pulmonary & Critical Care Medicine, University of Miami/Jackson Memorial Medical Center
• Jeffrey Golden, MD, Medical Director, Lung Transplantation Director, Interstitial Lung Disease Clinic University of California, San Francisco
• Harold Collard, MD, University of California, San Fra
  '/>"/>